Understanding the cellular mode of action of vernakalant using a computational model: answers and new questions
Vernakalant is a new antiarrhythmic agent for the treatment of atrial fibrillation. While it has proven to be effective in a large share of patients in clinical studies, its underlying mode of action is not fully understood. In this work, we aim to link experimental data from the subcellular, tissue...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2015-09-01
|
| Series: | Current Directions in Biomedical Engineering |
| Subjects: | |
| Online Access: | http://www.degruyter.com/view/j/cdbme.2015.1.issue-1/cdbme-2015-0101/cdbme-2015-0101.xml?format=INT |